Cargando…

DICER1 Syndrome: DICER1 Mutations in Rare Cancers

DICER1 syndrome is a rare genetic disorder that predisposes individuals to multiple cancer types. Through mutations of the gene encoding the endoribonuclease, Dicer, DICER1 syndrome disrupts the biogenesis and processing of miRNAs with subsequent disruption in control of gene expression. Since the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, Jake C., Jorcyk, Cheryl L., Oxford, Julia Thom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977116/
https://www.ncbi.nlm.nih.gov/pubmed/29762508
http://dx.doi.org/10.3390/cancers10050143
_version_ 1783327308430442496
author Robertson, Jake C.
Jorcyk, Cheryl L.
Oxford, Julia Thom
author_facet Robertson, Jake C.
Jorcyk, Cheryl L.
Oxford, Julia Thom
author_sort Robertson, Jake C.
collection PubMed
description DICER1 syndrome is a rare genetic disorder that predisposes individuals to multiple cancer types. Through mutations of the gene encoding the endoribonuclease, Dicer, DICER1 syndrome disrupts the biogenesis and processing of miRNAs with subsequent disruption in control of gene expression. Since the first description of DICER1 syndrome, case reports have documented novel germline mutations of the DICER1 gene in patients with cancers as well as second site mutations that alter the function of the Dicer protein expressed. Here, we present a review of mutations in the DICER1 gene, the respective protein sequence changes, and clinical manifestations of DICER1 syndrome. Directions for future research are discussed.
format Online
Article
Text
id pubmed-5977116
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-59771162018-05-31 DICER1 Syndrome: DICER1 Mutations in Rare Cancers Robertson, Jake C. Jorcyk, Cheryl L. Oxford, Julia Thom Cancers (Basel) Review DICER1 syndrome is a rare genetic disorder that predisposes individuals to multiple cancer types. Through mutations of the gene encoding the endoribonuclease, Dicer, DICER1 syndrome disrupts the biogenesis and processing of miRNAs with subsequent disruption in control of gene expression. Since the first description of DICER1 syndrome, case reports have documented novel germline mutations of the DICER1 gene in patients with cancers as well as second site mutations that alter the function of the Dicer protein expressed. Here, we present a review of mutations in the DICER1 gene, the respective protein sequence changes, and clinical manifestations of DICER1 syndrome. Directions for future research are discussed. MDPI 2018-05-15 /pmc/articles/PMC5977116/ /pubmed/29762508 http://dx.doi.org/10.3390/cancers10050143 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Robertson, Jake C.
Jorcyk, Cheryl L.
Oxford, Julia Thom
DICER1 Syndrome: DICER1 Mutations in Rare Cancers
title DICER1 Syndrome: DICER1 Mutations in Rare Cancers
title_full DICER1 Syndrome: DICER1 Mutations in Rare Cancers
title_fullStr DICER1 Syndrome: DICER1 Mutations in Rare Cancers
title_full_unstemmed DICER1 Syndrome: DICER1 Mutations in Rare Cancers
title_short DICER1 Syndrome: DICER1 Mutations in Rare Cancers
title_sort dicer1 syndrome: dicer1 mutations in rare cancers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977116/
https://www.ncbi.nlm.nih.gov/pubmed/29762508
http://dx.doi.org/10.3390/cancers10050143
work_keys_str_mv AT robertsonjakec dicer1syndromedicer1mutationsinrarecancers
AT jorcykcheryll dicer1syndromedicer1mutationsinrarecancers
AT oxfordjuliathom dicer1syndromedicer1mutationsinrarecancers